Results 151 to 160 of about 223,350 (308)

Effects of Add‐On Icosapent Ethyl With Standard Treatment on Functional Outcomes and Inflammatory Biomarkers in Acute Ischemic Stroke: A Blinded Randomized Controlled Trial

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background Ischemic stroke, a major cause of mortality and long‐term disability, results from the abrupt cessation of cerebral blood flow due to vascular occlusion or rupture. Icosapent Ethyl (EPA‐EE), approved for hypertriglyceridemia, has anti‐inflammatory and antithrombotic properties that may lessen ischemic damage.
Mitra Mahmoudi Meymand, Seyed Hossein Aghamiri, Saeed Mohmammad Soleymani, Shadiyeh Bararpoor Poshkohi, Samaneh Masoudi, Hadi Esmaily   +5 more
wiley   +1 more source

Rapid synthesis: Achieving net-zero emissions in health systems through strategic funding partnerships and networks

An in-depth synthesis of what is known based on the best available global research evidence (i.e., evidence syntheses) and local research evidence (i.e., single studies) and may include a scan of experiences from other countries and from Canadian ...
Jaspal, A, Alam, S, Moat, KA, DeMaio, P, Bain, T, Lavis, JN   +5 more
core  

Assessing global cities' climate policy with self-reported pledges, plans & targets on net-zero transition

With the accelerated global momentum towards a net zero economy, cities are increasingly serving as agents of decarbonisation and setting ambitious climate targets.
Ling, Chester Yuxuan
core  

Sharing the effort: Annual Net-Zero Report 2024 [PDF]

Countries around the world have committed to reducing greenhouse gas (GHG) emissions in line with the Paris Agreement’s goal of ‘limiting global temperature rise to well below 2 °C and pursue efforts to limit it to 1.5 °C’ (UNFCCC, 2015a).
Dafnomilis, I., Brutschin, E., Kriegler, E., Sovacool, B., Tagomori, I., Riahi, K., Hooijschuur, E., Pelz, S., van Vuuren, D., Würschinger, C., Dekker, M., Kikstra, J.   +11 more
core  

Baseline Neuroinflammation Stratifies TSPO‐PET Response to Disease‐Modifying Therapy in Multiple Sclerosis

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To investigate which baseline clinical and imaging characteristics best predict TSPO‐PET‐measurable reduction in glial activation following treatment of multiple sclerosis (MS), to utilize this information for designing more efficient biomarker‐based clinical trials targeting glial activation.
Marlene T. Morch, Markus Matilainen, Giulia N. Baldrighi, Marjo Nylund, Maija Saraste, Laura Airas   +5 more
wiley   +1 more source

Blurring evidence with advocacy: a systematic review of policy recommendations for net zero. [PDF]

NPJ Environ Soc Sci
Danopoulos E, Shah A, Schneider CR, Aston JAD.   +3 more
europepmc   +1 more source

A review of net-zero greenhouse gas (GHG) emission non-regulatory environmental building standards and frameworks

Non-regulatory environmental building standards have been used in the built environment for more than thirty years and have had considerable influence over building development and policy.
Robertson, Craig, Mumovic, Dejan, Hatherley, Simon, Burman, Esfand   +3 more
core   +1 more source

Evaluating a Pragmatic Strength Alternative for Frailty Measurement and Assessing Its Predictive Capacity Against Established Frailty Instruments in Rheumatoid Arthritis

Arthritis Care &Research, EarlyView.
Objective Frailty occurs prematurely in rheumatoid arthritis (RA) and is associated with poor health outcomes. We compared the performance of four frailty instruments, including a pragmatic alternative measure using chair sit‐to‐stand (STS), and evaluated their abilities to predict poor health outcomes.
Kylie E. Riggles, Hannah F. Brubeck, Adrienne D. Tanus, Courtney N. Loecker, Punyasha Roul, Bryant R. England, Elizabeth R. Wahl, James S. Andrews, Namrata Singh, Joshua F. Baker, Patricia P. Katz, Dolores M. Shoback, Jose M. Garcia, Ariela R. Orkaby, Katherine D. Wysham   +14 more
wiley   +1 more source

Pathways to cost-optimal and net-zero emissions irrigation in the United States. [PDF]

Nat Commun
Späte J, Mingolla S, Rosa L.
europepmc   +1 more source

Clinical Significance of Therapeutic Drug Level Monitoring for Mycophenolate in Patients With Extrarenal Systemic Lupus Erythematosus—A Systematic Review and Meta‐Analysis

Arthritis Care &Research, EarlyView.
Objective Clinical response to mycophenolic acid (MPA) is highly heterogeneous; thus, therapeutic drug level monitoring (TDM) may help improve treatment efficacy. This systematic review and meta‐analysis examined therapeutic ranges for MPA levels associated with better outcomes and safety in patients with systemic lupus erythematosus (SLE ...
Zahraa Qamhieh, Dalia Sriwi, Callie Saric, Tripti Singh, Christie M. Bartels, Shivani Garg   +5 more
wiley   +1 more source